RASSF1 and head and neck squamous cell carcinoma: Our meta-analysis identified an association between aberrant rmethylation of RASSF1A promoter with HNSCC, which indicated that hypermethylation of RASSF1A promoter might be a potential biomarker in the process of HNSCC.